URGN
UroGen Pharma Ltd.
$20.47
+$0.62(+3.12%)
51
Overall
40
Value
63
Tech
50
Quality
Market Cap
$933.61M
Volume
813.55K
52W Range
$3.42 - $21.71
Target Price
$33.75
Key Metrics Overview
| Market Cap | $933.61M | P/E Ratio | N/A |
| 52W High | $21.71 | 52W Low | $3.42 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 15.8% | 52W Position | 93.2% |
| Overall Score | 51 | Value Score | 40 |
| Quality Score | 50 | Technical Score | 63 |
Growth Analysis
| EPS Current Est | $-3.18 | EPS Next Est | $-1.17 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | URGN | $20.47 | +3.1% | 813.55K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |